Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exubera inhaled insulin: a review.

A H Barnett1

  • 1University of Birmingham and Birmingham Heartlands Hospital, Department of Medicine-Undergraduate Centre, Birmingham, UK. anthony.barnett@heartsol.wmids.nhs.uk

International Journal of Clinical Practice
|May 27, 2004
PubMed
Summary

Inhaled insulin, like Exubera, offers a needle-free way to manage blood sugar for diabetes patients. This novel delivery method shows comparable glycaemic control to injections, potentially improving patient adherence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NICE guidelines for Type 2 diabetes: revised but still not fit for purpose.

Diabetic medicine : a journal of the British Diabetic Association·2015
Same author

Novel therapeutics for type 2 diabetes: insulin resistance.

Diabetes, obesity & metabolism·2014
Same author

What factors influence concordance with medications? Findings from the U.K. Asian Diabetes study.

Diabetic medicine : a journal of the British Diabetic Association·2014
Same author

Safety and efficacy of the dipeptidyl peptidase-4 inhibitor linagliptin in elderly patients with type 2 diabetes: a comprehensive analysis of data from 1331 individuals aged ≥ 65 years.

Diabetes, obesity & metabolism·2014
Same author

Incidence, worry and discussion about dosing irregularities and self-treated hypoglycaemia amongst HCPs and patients with type 2 diabetes: results from the UK cohort of the Global Attitudes of Patient and Physicians (GAPP2) survey.

International journal of clinical practice·2014
Same author

Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: a systematic review and network meta-analysis.

Diabetes, obesity & metabolism·2013

Area of Science:

  • Endocrinology
  • Pharmacology
  • Diabetes Management

Background:

  • Fear of hypoglycemia and reluctance towards multiple daily injections hinder glycemic control in diabetes.
  • Current insulin delivery methods present challenges for patient adherence and physiological replacement.

Purpose of the Study:

  • To review inhaled insulin (Exubera) as a novel prandial insulin delivery method.
  • To discuss the implications of needle-free insulin administration for diabetes patients.

Main Methods:

  • Literature review of studies on inhaled insulin (Exubera).
  • Analysis of glycaemic control and safety data.
  • Discussion of patient compliance and treatment target attainment.

Main Results:

  • Inhaled insulin provides physiological prandial insulin replacement with non-invasive delivery.
  • Glycaemic control comparable to subcutaneous insulin preparations has been demonstrated.
  • No unexpected safety concerns have been reported with inhaled insulin.

Conclusions:

  • Inhaled insulin offers a viable alternative to injections for diabetes management.
  • Improved patient compliance may be achieved with needle-free insulin technologies.
  • This approach facilitates the attainment of treatment targets in diabetes care.

Related Experiment Videos